Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Korro Bio (KRRO) Shares Outstanding (Weighted Average) (2019 - 2025)

Korro Bio's Shares Outstanding (Weighted Average) history spans 7 years, with the latest figure at $9.4 million for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 5.32% year-over-year to $9.4 million, compared with a TTM value of $9.4 million through Dec 2025, up 5.32%, and an annual FY2025 reading of $9.4 million, up 5.32% over the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $9.4 million at Korro Bio, roughly flat from $9.4 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $36.9 million in Q3 2023, with the low at $255175.0 in Q4 2022.
  • Average Shares Outstanding (Weighted Average) over 5 years is $17.7 million, with a median of $9.4 million recorded in 2025.
  • Year-over-year, Shares Outstanding (Weighted Average) plummeted 99.26% in 2022 and then soared 3150.32% in 2024.
  • Tracing KRRO's Shares Outstanding (Weighted Average) over 5 years: stood at $34.4 million in 2021, then plummeted by 99.26% to $255175.0 in 2022, then skyrocketed by 499.32% to $1.5 million in 2023, then surged by 483.3% to $8.9 million in 2024, then rose by 5.32% to $9.4 million in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Shares Outstanding (Weighted Average) are $9.4 million (Q4 2025), $9.4 million (Q3 2025), and $9.4 million (Q2 2025).